AIMS/HYPOTHESIS: NEFA play a key role in the setting of insulin resistance and hyperinsulinaemia, which are both features of the prediabetic state. In addition to the direct effects on pancreas and peripheral tissues, NEFA have been reported to act via changes in autonomic nervous system activity. The present study was aimed at studying the effects of a local increase in NEFA in the brain on glucose-induced insulin secretion (GIIS) and on insulin action. We hypothesised that cerebral NEFA beta oxidation is a prerequisite for these central effects. METHODS: Male Wistar rats were infused with Intralipid/heparin for 24 h through the carotid artery towards the brain (IL rats), after which we performed the GIIS test, a euglycaemic-hyperinsulinaemic clamp and c-fos immunochemistry. In another series of experiments, Intralipid/heparin infusion was coupled with lateral ventricular infusion of etomoxir, a CPT1 inhibitor, which was initiated 5 days previously. RESULTS: During the infusion period, there were no changes in plasma NEFA, insulin or glucose concentrations. IL rats displayed an increased GIIS compared with control rats (C rats) infused with saline/heparin, and their liver insulin sensitivity was decreased. Furthermore, lipid infusion induced a significant decrease in c-fos-like immunoreactive neurons in medial hypothalamic nuclei, and an increase in lateral hypothalamus. Neuronal activation profile was almost normalised in IL rats infused with etomoxir, and GIIS was strongly decreased, possibly because of the concomitant normalisation of hepatic glucose output. CONCLUSIONS/ INTERPRETATION: These results strongly suggest that beta oxidation is required for the central effects of NEFA on GIIS.
AIMS/HYPOTHESIS: NEFA play a key role in the setting of insulin resistance and hyperinsulinaemia, which are both features of the prediabetic state. In addition to the direct effects on pancreas and peripheral tissues, NEFA have been reported to act via changes in autonomic nervous system activity. The present study was aimed at studying the effects of a local increase in NEFA in the brain on glucose-induced insulin secretion (GIIS) and on insulin action. We hypothesised that cerebral NEFA beta oxidation is a prerequisite for these central effects. METHODS: Male Wistar rats were infused with Intralipid/heparin for 24 h through the carotid artery towards the brain (IL rats), after which we performed the GIIS test, a euglycaemic-hyperinsulinaemic clamp and c-fos immunochemistry. In another series of experiments, Intralipid/heparin infusion was coupled with lateral ventricular infusion of etomoxir, a CPT1 inhibitor, which was initiated 5 days previously. RESULTS: During the infusion period, there were no changes in plasma NEFA, insulin or glucose concentrations. IL rats displayed an increased GIIS compared with control rats (C rats) infused with saline/heparin, and their liver insulin sensitivity was decreased. Furthermore, lipid infusion induced a significant decrease in c-fos-like immunoreactive neurons in medial hypothalamic nuclei, and an increase in lateral hypothalamus. Neuronal activation profile was almost normalised in IL rats infused with etomoxir, and GIIS was strongly decreased, possibly because of the concomitant normalisation of hepatic glucose output. CONCLUSIONS/ INTERPRETATION: These results strongly suggest that beta oxidation is required for the central effects of NEFA on GIIS.
Authors: R Bränström; C A Aspinwall; S Välimäki; C-G Ostensson; A Tibell; M Eckhard; H Brandhorst; B E Corkey; P-O Berggren; O Larsson Journal: Diabetologia Date: 2004-01-23 Impact factor: 10.122
Authors: Christelle Le Foll; Boman G Irani; Christophe Magnan; Ambrose A Dunn-Meynell; Barry E Levin Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-06-17 Impact factor: 3.619
Authors: C Cansell; J Castel; R G P Denis; C Rouch; A-S Delbes; S Martinez; D Mestivier; B Finan; J G Maldonado-Aviles; M Rijnsburger; M H Tschöp; R J DiLeone; R H Eckel; S E la Fleur; C Magnan; T S Hnasko; S Luquet Journal: Mol Psychiatry Date: 2014-04-15 Impact factor: 15.992
Authors: Samuel C Haywood; Adam J Bree; Erwin C Puente; Dorit Daphna-Iken; Simon J Fisher Journal: Am J Physiol Endocrinol Metab Date: 2009-05-05 Impact factor: 4.310